Pereiti į pagrindinį turinį
Home
language-selector-globe Lithuania | lt
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Lithuania
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Apie mus 
      • Novartis Lietuvoje 
      • Strategija 
      • Įvairovė ir įtrauktis 
      • Žmonės ir kultūra 
      • Produktai 
      • Susisiekite su mumis 
      Apie mus Apie mus
    • Pacientai ir slaugytojai 
      • Novartis įsipareigojimas pacientams ir slaugytojams 
      • Terapinės sritys 
      • Produktai 
      • Pranešti apie nepageidaujamą reiškinį 
        • Pranešti apie įtariamą nepageidaujamą reiškinį 
      • Parama pacientų organizacijoms 
      Gydytojas tikrina paciente su stratoskopu Pacientai ir slaugytojai
    • Sveikatos priežiūros specialistai 
      • Novartis interneto svetainė sveikatos priežiūros specialistams 
      • Produktai 
      • Novartis vystomų produktų asortimentas 
      • Pranešti apie nepageidaujamą reiškinį 
      • Bendradarbiavimas su sveikatos priežiūros specialistais 
      • Novartis klinikiniai tyrimai 
      Gydytojai kalbasi ligonineje Sveikatos priežiūros specialistai
    • Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV) 
      • Etika, rizikos valdymas ir atitiktis 
      • Prieinamumas 
      • Aplinkos tvarumas 
      • Pasaulinė sveikatos apsauga 
      • Etiškas elgesys 
        • Etikos kodeksas 
    • Naujienos 
      • Naujienų archyvas 
      • Susisiekite su mumis 
      A photo of people in a meeting hall Naujienos
    • Karjera 
      • Karjeros paieška 
      • Mūsų komandos 
      • Asmeninis augimas 
      • Jaunieji talentai 
      • Kaip mes dirbame 
      • Darbuotojų gerovė 
      • Įvairovė ir įtrauktis 
      • Apdovanojimai ir pripažinimas 
      Karjera Karjera
    • Koronavirusas 
      coronavirus-microscope-image Koronavirusas
    Vilniaus panorama Pagrindinis puslapis
  1. Pagrindinis puslapis
  2. Karjera
  3. Karjeros paieška
  • Sort by Sort ascending
  • Darbo pavadinimas Sort descending
  • Svetainė
  • Vieta
  • Padalinys
  • Veikla
  • Functional Area
  • Paskelbimo data
Darbo pavadinimas Sort descending Svetainė Vieta Padalinys Veikla Functional Area Paskelbimo data
Patient Advocacy Manager Prague Czech Republic International Innovative Medicines Research & Development Spa 10, 2024
Patient Safety Head US East Hanover USA Development Innovative Medicines Research & Development Bir 28, 2024
Patient Safety Manager Paris Headquarter (Novartis Pharma S.A.S.) France Development Innovative Medicines Research & Development Rug 04, 2024
Patient Safety Specialist İstanbul Kavacık Turkey Development Innovative Medicines Research & Development Bir 10, 2024
Patient Safety Specialist Amiria Egypt Development Innovative Medicines Research & Development Rugp 26, 2024
Pipeline Medical Manager CRM London (The Westworks) United Kingdom International Innovative Medicines Research & Development Spa 11, 2024
Principal /Senior Principal Scientist PKS Oncology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Gegužė 20, 2024
Principal Biostatistician Shanghai (Shanghai) China Development Innovative Medicines Research & Development Bir 20, 2024
Principal Biostatistician Home Worker United Kingdom Development Innovative Medicines Research & Development Rug 17, 2024
Principal Clinical Data Manager Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Rug 26, 2024
Principal Pharmacometrics Scientist London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Rug 03, 2024
Principal RWE Research Analyst Hyderabad (Office) India Operations CTS Research & Development Gegužė 14, 2024
Principal RWE Research Analyst Hyderabad (Office) India Operations CTS Research & Development Bir 06, 2024
Principal Scientific Writer Hyderabad (Office) India Operations CTS Research & Development Rug 03, 2024
Principal Scientist Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Bal 24, 2024
Principal Scientist - Pathology Telangana India Biomedical Research Pharma Research Research & Development Rug 03, 2024
Principal Scientist – Covalency & Exploratory Chemical Biology Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Rugp 15, 2024
Principal Scientist 2 - Preclinical Safety Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Lie 22, 2024
Principal Scientist I - Oncology Pathology and Biomarkers (80-100%*) Basel (City) Switzerland Biomedical Research Pharma Research Research & Development Rug 05, 2024
Principal Scientist II, Cell & Gene Therapy Delivery San Diego USA Biomedical Research Pharma Research Research & Development Spa 17, 2024
Principal Scientist II, Emerging Technologies Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Rug 09, 2024
Principal Scientist, Modeling & Simulation RLT Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Rug 03, 2024
Principle Scientist, Molecular Imaging Expert Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Rugp 18, 2024
Process Expert (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Lie 24, 2024
Product Manager - Research Informatics (Sample Shipping and Compliance) Hyderabad (Office) India Biomedical Research Pharma Research Research & Development Rug 03, 2024
Project Team Coordinator (Medical) (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Spa 15, 2024
QC Senior Scientist Ivrea Italy International Innovative Medicines Research & Development Spa 14, 2024
Qualification Expert (m/f/d) Ivrea Italy International Innovative Medicines Research & Development Lie 23, 2024
RA CMC Associate Manager - II Hyderabad (Office) India Development Innovative Medicines Research & Development Bir 19, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development Rug 03, 2024
RA CMC Associate Manager-II Hyderabad (Office) India Development Innovative Medicines Research & Development Gegužė 30, 2024
RA CMC Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Rug 03, 2024
RA CMC Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Rug 03, 2024
RA CMC Senior Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Rug 03, 2024
RA Manager INSURGENTES Mexico Development Innovative Medicines Research & Development Rug 03, 2024
RA Manager, Procedural Documents London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Rug 10, 2024
RA Operational Excellence Junior Associate – MEA Dubai Utd.Arab Emir. Development Innovative Medicines Research & Development Spa 16, 2024
RA Specialist Croatia Croatia Development Innovative Medicines Research & Development Spa 18, 2024
Regulatory Affairs CMC Associate Director Schaftenau Austria Development Innovative Medicines Research & Development Rug 30, 2024
Regulatory Affairs CMC Senior Manager Schaftenau Austria Development Innovative Medicines Research & Development Rug 02, 2024
Regulatory Affairs Manager Kyiv Ukraine Development Innovative Medicines Research & Development Gegužė 10, 2024
Regulatory Affairs Manager New South Wales (NSW) Australia Development Innovative Medicines Research & Development Spa 06, 2024
Regulatory Affairs Manager Beijing (Beijing) China Development Innovative Medicines Research & Development Rug 01, 2024
Regulatory Affairs Medical Device Manager (Schaftenau, Austria) Schaftenau Austria Development Innovative Medicines Research & Development Rug 02, 2024
Renal Medical Lead Seoul South Korea International Innovative Medicines Research & Development Rug 01, 2024
Research Informatics Product Growth Manager x3 (US or Switzerland) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Gegužė 08, 2024
Research Scientist - Lab Technician (Dual Posting) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Rug 26, 2024
Research Scientist I San Diego USA Biomedical Research Pharma Research Research & Development Lie 24, 2024
Research Scientist II San Diego USA Biomedical Research Pharma Research Research & Development Spa 01, 2024
Research Scientist, Cell Pharmacology - CVM Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Spa 16, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • › Next page

Novartis Lietuvoje

Naršyti Novartis svetainėje
  • Pacientai ir slaugytojai
  • Sveikatos priežiūros specialistai
  • Kompanijos etika
  • Naujienos
  • Karjera
Naujienos
  • Naujienų archyvas
Musų portfelis
  • Novartis vystomų produktų asortimentas
  • Novartis produktai
Kitos Novartis svetainės
  • Pasaulinė svetainė
Footer Bottom
© 2024 Novartis AG
  • Privatumo politika
  • Naudojimo sąlygos
  • Slapukai
  • Slapukų nustatymai
  • Svetainės schema
  • Svetainės prieinamumas
Novartis svetainių katalogas
Ši svetainė skirta Lietuvos gyventojams